NEW YORK (GenomeWeb News) - Shares in Molecular Devices were down 24 percent, or $6.88, to $22.16 in mid-afternoon trading today after the company reported lackluster results for its second quarter.

As GenomeWeb News reported today, Molecular Devices reported a net loss of $460,000 for the quarter, compared to a profit year over year of $3.7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.